Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
An immunologist shares tips from a team-based environment
NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics
Jennifer Allport-Anderson hunts for cardiac cures.
Read a patient’s perspective on living with a rare, life-threatening blood cancer called myelofibrosis and why it’s important to rally the community.
Ambitious scientist accelerates research into African genomic diversity and health challenges with internship
Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.
While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.
Compounds block a protein involved in many cancers by cementing it shut.
Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.
Researchers focus on reversing the scarring that’s common to liver diseases.
Did you know migraine is the most common of all neurological disorders? Learn more surprising facts.